(Q40757720)

23 September 2017

title

Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition (English)

1 reference

23 September 2017

1 reference

6

Marie-Agnès Dillies

1 reference

23 September 2017

0 references

Matthieu Galtier

1

1 reference

23 September 2017

Luisa De Sordi

2

1 reference

23 September 2017

Damien Maura

3

1 reference

23 September 2017

Harindra Arachchi

4

1 reference

23 September 2017

Stevenn Volant

5

1 reference

23 September 2017

Laurent Debarbieux

7

1 reference

23 September 2017

publication date

11 March 2016

1 reference

Environmental Microbiology

23 September 2017

published in

1 reference

23 September 2017

volume

18

1 reference

23 September 2017

issue

7

1 reference

23 September 2017

page(s)

2237-2245

1 reference

Phage treatment of human infections.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Phenotypic and genotypic assays for the detection and identification of adhesins from pyelonephritic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Bacterial sensing of bacteriophages in communities: the search for the Rosetta stone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Effects of antibiotics on human microbiota and subsequent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Rapid evolution of the human gut virome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Escherichia coli ST131, an intriguing clonal group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Disease-specific alterations in the enteric virome in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Control of brain development, function, and behavior by the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

A randomized clinical trial to evaluate the preventive effect of cranberry juice (UR65) for patients with recurrent urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Analysis of 16S rRNA amplicon sequencing options on the Roche/454 next-generation titanium sequencing platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Infection control in the multidrug-resistant era: tending the human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Uropathogenic Escherichia coli mediated urinary tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

MicroScope--an integrated microbial resource for the curation and comparative analysis of genomic and metabolic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

MICROBIOLOGY. Phage therapy redux--What is to be done?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

The management of urinary infections; what have we learned in the past decade?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1462-2920.13284

21 January 2018

Identifiers

DOI

10.1111/1462-2920.13284

1 reference

release_zpxfvq5lynf5zjgo2ona2n5bky

23 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zpxfvq5lynf5zjgo2ona2n5bky

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference